525 related articles for article (PubMed ID: 30013345)
1. Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review.
Muhamad N; Plengsuriyakarn T; Na-Bangchang K
Int J Nanomedicine; 2018; 13():3921-3935. PubMed ID: 30013345
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic studies of nanoparticles as a delivery system for conventional drugs and herb-derived compounds for cancer therapy: a systematic review.
Abdifetah O; Na-Bangchang K
Int J Nanomedicine; 2019; 14():5659-5677. PubMed ID: 31632004
[TBL] [Abstract][Full Text] [Related]
3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-based drug nanocarriers as a novel drug delivery system for cancer chemotherapy: A systematic review.
Salari N; Mansouri K; Valipour E; Abam F; Jaymand M; Rasoulpoor S; Dokaneheifard S; Mohammadi M
Daru; 2021 Dec; 29(2):439-447. PubMed ID: 34499323
[TBL] [Abstract][Full Text] [Related]
5. Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy.
Zhong Y; Meng F; Deng C; Zhong Z
Biomacromolecules; 2014 Jun; 15(6):1955-69. PubMed ID: 24798476
[TBL] [Abstract][Full Text] [Related]
6. A Review on Targeting Nanoparticles for Breast Cancer.
Alqaraghuli HGJ; Kashanian S; Rafipour R
Curr Pharm Biotechnol; 2019; 20(13):1087-1107. PubMed ID: 31364513
[TBL] [Abstract][Full Text] [Related]
7. Design of Targeted Nanostructured Coordination Polymers (NCPs) for Cancer Therapy.
Novio F
Molecules; 2020 Jul; 25(15):. PubMed ID: 32751178
[TBL] [Abstract][Full Text] [Related]
8. Nanocarriers for cancer-targeted drug delivery.
Kumari P; Ghosh B; Biswas S
J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
[TBL] [Abstract][Full Text] [Related]
9. Precision Cancer Nanotherapy: Evolving Role of Multifunctional Nanoparticles for Cancer Active Targeting.
Ahmad A; Khan F; Mishra RK; Khan R
J Med Chem; 2019 Dec; 62(23):10475-10496. PubMed ID: 31339714
[TBL] [Abstract][Full Text] [Related]
10. The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer.
Lee WH; Loo CY; Leong CR; Young PM; Traini D; Rohanizadeh R
Expert Opin Drug Deliv; 2017 Aug; 14(8):937-957. PubMed ID: 27759437
[TBL] [Abstract][Full Text] [Related]
11. [Progress of mesoporous silica nanoparticles in targeting drug delivery system of antitumor drug].
Zhang HM; Mo S; Liu XQ; Han FM; Wang JY; Wang ZM
Zhongguo Zhong Yao Za Zhi; 2015 Sep; 40(17):3450-5. PubMed ID: 26978988
[TBL] [Abstract][Full Text] [Related]
12. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
Li X; Zhao Q; Qiu L
J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles-mediated drug delivery approaches for cancer targeting: a review.
Sultana S; Khan MR; Kumar M; Kumar S; Ali M
J Drug Target; 2013 Feb; 21(2):107-25. PubMed ID: 22873288
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
15. Colon cancer therapy: recent developments in nanomedicine to improve the efficacy of conventional chemotherapeutic drugs.
Prados J; Melguizo C; Ortiz R; Perazzoli G; Cabeza L; Alvarez PJ; Rodriguez-Serrano F; Aranega A
Anticancer Agents Med Chem; 2013 Oct; 13(8):1204-16. PubMed ID: 23574385
[TBL] [Abstract][Full Text] [Related]
16. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.
Huynh NT; Roger E; Lautram N; Benoît JP; Passirani C
Nanomedicine (Lond); 2010 Nov; 5(9):1415-33. PubMed ID: 21128723
[TBL] [Abstract][Full Text] [Related]
17. Functionalized liposomes as drug nanocarriers for active targeted cancer therapy: a systematic review.
Abbasi H; Rahbar N; Kouchak M; Khalil Dezfuli P; Handali S
J Liposome Res; 2022 Jun; 32(2):195-210. PubMed ID: 33729077
[TBL] [Abstract][Full Text] [Related]
18. Application of capsaicin as a potential new therapeutic drug in human cancers.
Zhang S; Wang D; Huang J; Hu Y; Xu Y
J Clin Pharm Ther; 2020 Feb; 45(1):16-28. PubMed ID: 31545523
[TBL] [Abstract][Full Text] [Related]
19. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
20. Promising effects of nanomedicine in cancer drug delivery.
Wakaskar RR
J Drug Target; 2018 Apr; 26(4):319-324. PubMed ID: 28875739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
